UnknownNot Applicable

Effect of Different VV ECMO Flows on Lung Perfusion Monitored by EIT

China15 participantsStarted 2023-01-01

Plain-language summary

The purpose of this study is to investigate the feasibility of using electric impedance tomography (EIT) to monitor lung perfusion during veno-venous (VV) extracopreal membrane oxygenation (ECMO) support, as well as the effect of different ECMO flows on lung perfusion monitored by EIT.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients aged ≥ 18 and ≤ 70 years；
✓. Patients supported with VV ECMO for respiratory failure；
✓. Patients are intubated and mechanically ventilated.

Exclusion criteria

✕. EIT contraindications such as chest wound dressing, pacemaker installation, defibrillator, etc;
✕. Patients who did not sign the informed consent form;
✕. Pulmonary embolism;
✕. Pneumothorax;
✕. Medium to plenty of chest water;
✕. Atrial fibrillation or other malignant arrhythmia leads to a decrease in cardiac output;
✕. Refractory shock;
✕. Severe chronic heart and lung disease has existed in the past;

What they're measuring

Lung perfusion at different VV ECMO flows

Timeframe: up to 24hour

Trial details

NCT IDNCT05778292

SponsorUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-31

Contact for this trial

Xiaobo Yang, prof.

008602785351606 want.tofly@aliyun.com

View on ClinicalTrials.gov More Critical Illness trials